FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE® (palbociclib) in HR+, HER2- Metastatic Breast Cancer December 22, 2016 Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA) for its first-in-class CDK 4/6 inhibitor, IBRANCE® (palbociclib). The [..]
Microbiotica: Sangar Institute Spin-out; Will Get £8m Funding From Cambridge Innovation Capital plc and IP Group plc By : Media Team Sangar Institute December 21, 2016 Cambridge Innovation Capital plc (CIC), a Cambridge-based investor in technology and healthcare companies, and IP Group plc, the developer of intellectual property-based businesses, announce the creation [..]
Sangar Institute Research Reveal Potential Drug Target From Largest Ever Genetic study of Primary Sclerosing Cholangitis By : Media Team Sangar Institute December 21, 2016 Primary Sclerosing Cholangitis (PSC) is a debilitating rare disease of the liver with no effective treatment. Reported in Nature Genetics researchers from the Wellcome Trust Sanger [..]
New Diabetes Approaches From Bacteria That Boost Insulin-Producing Cells By Lewis Taylor, University Communications December 21, 2016 A newly discovered bacterial protein produced in the zebrafish gut triggers insulin-producing beta cells of the pancreas to multiply during early larval development, say University of Oregon researchers. The research potentially has human health [..]
FDA Approved Rubraca™ (Rucaparib) of Clovis Oncology For the Treatment of Advanced Ovarian Cancer due to BRCA Mutations December 20, 2016 Rubraca received approval under the FDA’s accelerated approval program based on objective response rate and duration of response Most common Grade 3-4 adverse reaction was anemia; most common Grade 3-4 laboratory [..]
Pfizer Receives Approval in the European Union for Nimenrix™ (Meningococcal Group A, C, W-135, and Y Conjugate Vaccine) in Infants Six Weeks of Age and Older Pfizer NEWS December 20, 2016 Pfizer Inc. (NYSE:PFE) announced that the European Commission (EC) has approved an expanded indication for Nimenrix™ (meningococcal group [..]
Open Source Leadership Summit 2017 Dates: February 14-16, 2017 | Request an invitation here Submit a speaking proposal here Location: Lake Tahoe, The United States The Linux Foundation Open Source Leadership Summit is where the world’s thought leaders in open source software and collaborative development convene to share best practices and learn how [..]
Movable Microplatform Floats On a Sea of Droplets David L. Chandler | MIT News Office December 19, 2016 Microelectromechanical systems, or MEMS, are tiny machines fabricated using equipment and processes developed for the production of electronic chips and devices. They’ve found a wide variety of applications in today’s consumer electronics, [..]
A Leap in Bioinspired Robotics Jennifer Chu | MIT News Office December 19, 2016 In the not so distant future, first responders to a disaster zone may include four-legged, dog-like robots that can bound through a fire or pick their way through a minefield, rising up on their hind legs to [..]
Faster treatment for epilepsy NUS News 16 December 2016 Researchers at Duke-NUS Medical School (Duke-NUS) have identified a gene network in the brain, that when disrupted, causes epilepsy. The team’s original “network biology” approach could also possibly provide a quicker and cheaper way to accelerate the discovery of novel drug [..]
FDA Clears Integration Between LifeScan’s OneTouch Verio Flex® Blood Glucose Monitoring System and WellDoc’s BlueStar® Diabetes Management Platform J&J News December 17, 2016 LifeScan, Inc., part of the Johnson & Johnson Diabetes Care Companies and a world leader in blood glucose monitoring, today announced the U.S. Food and Drug Administration (FDA) [..]
Novartis receives positive CHMP recommendation for Ilaris® to treat rare diseases in adults and children called Periodic Fever Syndromes Ilaris® (canakinumab) is recommended for approval in Europe for the treatment of three Periodic Fever Syndromes: TRAPS, HIDS/MKD and FMF disease If approved, Ilaris will be the first and only [..]
Novartis bolsters innovative dermatology portfolio through acquisition of Ziarco Group Limited Investigational ZPL389 showed a clinically and statistically significant improvement of eczema lesions, leading to a 50% reduction in EASI score compared to placebo after eight weeks of treatment with a favorable safety profile Eczema is a chronic, [..]
FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX® (varenicline) Labeling Labeling Revisions Also Include Updates to Corresponding Warning and Addition of Clinical Data on Superior Efficacy of CHANTIX Compared to Bupropion or Nicotine Patch1 Labeling Revisions May Further Encourage Smokers and Healthcare Providers to Discuss Smoking [..]
KEYTRUDA® (pembrolizumab) Demonstrated Improved Health-Related Quality of Life Compared to Chemotherapy in First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Findings Presented in Plenary Session at 17 th World Conference on Lung Cancer December 16, 2016 Merck (NYSE:MRK), known as MSD outside the United States and Canada, [..]
How do we keep GPS safe from sabotage? By Edmund Andrews (Stanford News) December 16, 2016 Aerial drones are already being used to televise football games, produce 3-D maps and tend farm fields. Uber, the giant ride-sharing company, is now testing a service with self-driving cars in Pittsburgh. China deploys unmanned patrol boats in [..]
No more burning batteries? Stanford scientists turn to AI to create safer lithium-ion batteries DECEMBER 16, 2016 BY: MARK SHWARTZ (Stanford News) Scientists have spent decades searching for a safe alternative to the flammable liquid electrolytes used in lithium-ion batteries. Now Stanford University researchers have identified nearly two-dozen solid electrolytes [..]
U of T Researchers Make Skin Cells ‘Crawl’ Together to Heal Wounds Treated With Unique Hydrogel Layer December 16, 2016 By Marit Mitchell (University Of Toronto) Time may not heal all wounds, but a proprietary mix of peptides and gel developed by U of T researchers heals most. A team led [..]
FDA Approves MACI for the Treatment of Symptomatic Cartilage Defects of the Knee in Adults December 16, 2016 (GLOBE NEWSWIRE) Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced that the U.S. Food and Drug Administration [..]
MIT Energy Initiative report provides guidance for evolving electric power sector Emily Dahl | MIT Energy Initiative December 16, 2016 Distributed energy resources — relatively small-scale power technologies such as solar, wind, energy storage, and power electronics and control devices — are being deployed rapidly in the global shift toward [..]
SEO BootCamp January 11-13, 2017, Dallas, TX The SEO Bootcamp, organized by the SEO Bootcamp will take place from 11th January to 13th January 2017 at the Level in Dallas, United States Of America. This Conference Will Cover Areas Like: – What really matters to Google and other search engines, [..]
Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide) Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer By: Pfizer Press Release December 15, 2016 Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE:4503) today announced the Phase 4 PLATO study, evaluating the efficacy and safety of [..]
Pfizer Receives FDA Approval for EUCRISA™ (crisaborole), a Novel Non-Steroidal Topical Ointment for Mild to Moderate Atopic Dermatitis (Eczema) Pfizer News December 15, 2016 Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) approved EUCRISATM (crisaborole) ointment 2%, a novel non-steroidal topical phosphodieterase-4 (PDE-4) inhibitor for the treatment [..]
Big Data is Manageable: MIT Research By: Larry Hardesty | MIT News Office December 15, 2016 One way to handle big data is to shrink it. If you can identify a small subset of your data set that preserves its salient mathematical relationships, you may be able to perform useful [..]
Possible Drug Treatment For Incurable Brain Cancer University of Toronto News December 15, 2016 A team of University of Toronto researchers has identified promising drugs that could target a type of incurable brain cancer in children. That discovery is one of the potential outcomes of research described in the December 12 [..]
IBM Cloud Unveils New Features and Growing Momentum for Open Serverless Platform December 15 2016 IBM (NYSE: IBM) announced companies across a range of industries, including one of the world’s top banks, Santander Group, are designing and testing new apps with Bluemix OpenWhisk, IBM’s event-driven and open serverless computing platform. [..]
Drug Interactions Can Reduce Mortality in Breast Cancer Patients December 14, 2016 By: JENNIE DUSHECK (Stanford News) Patient health records revealed two drug combinations that may reduce mortality rates in breast cancer patients, according to a study led by researchers at the Stanford University School of Medicine. The drugs involved were [..]
A Cheaper and Better Blood Test to Manage Lung Cancer: Stanford Research December 14, 2016 By: JENNIE DUSHECK (Stanford News) Profiling the genes of lung-tumor cells from patient blood samples may be a cheap, noninvasive way to help doctors choose the right treatments, according to a study led by researchers at [..]
A Means to Control Catalytic Reactions: By U of Toronto Chemist December 14, 2016 By Sean Bettam Scientists at the University of Toronto have found a way to make catalysis – the use of catalysts to facilitate chemical reactions – more selective, breaking one chemical bond 100 times faster than [..]
Three Diseases and One Stone By: Elizabeth Dougherty December 14, 2016 In large swaths of rural Latin America, an insect called the kissing bug spreads a silent killer: Chagas disease. A bug bite can transfer a single-celled organism that takes up residence in several different tissues. People can live with these [..]
Copyright © 2024 | WordPress Theme by MH Themes